Bristol Myers Squibb wins approval for the first novel schizophrenia drug in decades; Pfizer pulls Oxbryta from the market; ...
We’re only a few months a way from the end of the year, but pharma companies still have a steady stream of clinical trial ...
The Food and Drug Administration in the US has just approved Cobenfy, which one researcher referred to as a "game changer" ...
Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other demyelinating diseases, today ...
Neurocrine Biosciences' stock dropped after a lackluster trial. Click here to read more about the potential for this biotech ...
Oct. 2, 2024 — Inside every cell, inside every nucleus, your continued existence depends on an incredibly complicated dance. Proteins are constantly wrapping and unwrapping DNA, and even minor ...
Sep. 27, 2024 — There is unexpectedly large variation in height growth in girls after their first period. Every second girl grows either more or less in length than the 6-8 centimeters that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback